POSTURE PICTURES AND OTHER TORTURES: THE BATTLE TO CONTROL ESTHER GREENWOOD’S BODY

Beginning in the 1940s and continuing into the 1960s, Dr. William H. Sheldon and his assistants took thousands of what became known as the “Posture Pictures” at the Ivy League, Seven Sister, and other colleges as well as at hospitals, factories, and prisons. Sheldon believed that there were three basic factors in human body types and that any given body could be mapped and charted using a three-digit code he called the “somatype.”[1] In the 1954 Atlas of Men, Sheldon published over one thousand examples of his eighty male somatypes at various ages and stages of life. Atlas of Men is a studbook as Sheldon identifies each somatype with a unique number and corresponding animal totem expressing the subject’s strength, relative intelligence, and virility. Sheldon begins to reveal the depths of the project’s duplicity when he states that “it may be a good thing, on the whole, that courses in somatyping are not yet generally taught in the women’s colleges” (209). While somatyping may not have been taught at the women’s colleges, patriarchal control of women’s bodies, enforced by fears of punishment for deviance from the norm, surely was. And that lesson stuck as evidenced by Sylvia Plath’s description of Posture Pictures in her autobiographical novel The Bell Jar (1963), published some thirteen years after she stood for her own Posture Picture as a new student at Smith College

Prelaunch testing of the GEOS-3 laser reflector array

The prelaunch testing performed on the Geos-3 laser reflector array before launch was used to determine the lidar cross section of the array and the distance of the center of gravity of the satellite from the center of gravity of reflected laser pulses as a function of incidence angle. Experimental data are compared to computed results

On Orbit Receiver Performance Assessment of the Geoscience Laser Altimeter System (GLAS) on ICESAT

The GLAS instrument on the NASA's ICESat mission has provided over a billion measurements of the Earth surface elevation and atmosphere backscattering at both 532 and 1064-nm wavelengths. The receiver performance has stayed nearly unchanged since ICESat launch in January 2003. The altimeter receiver has achieved a less than 3-cm ranging accuracy when excluding the effects of the laser beam pointing angle determination uncertainties. The receiver can also detect surface echoes through clouds of one-way transmission as low as 5%. The 532-nm atmosphere backscattering receiver can measure aerosol and clouds with cross section as low as 1e-7/m.sr with a 1 second integration time and molecular backscattering from upper atmosphere with a 60 second integration time. The 1064-nm atmosphere backscattering receiver can measure aerosol and clouds with a cross section as low as 4e-6/m.sr. This paper gives a detailed assessment of the GLAS receiver performance based on the in-orbit calibration tests

ICESat GLAS Altimetry Measurements: Received Signal Dynamic Range and Saturation Correction

NASAs Ice, Cloud, and land Elevation Satellite (ICESat), which operated between 2003 and 2009, made the first satellite-based global lidar measurement of Earths ice sheet elevations, sea-ice thickness and vegetation canopy structure. The primary instrument on ICESat was the Geoscience Laser Altimeter System (GLAS), which measured the distance from the spacecraft to Earths surface via the roundtrip travel time of individual laser pulses. GLAS utilized pulsed lasers and a direct detection receiver consisting of a silicon avalanche photodiode (SiAPD) and a waveform digitizer. Early in the mission, the peak power of the received signal from snow and ice surfaces was found to span a wider dynamic range than planned, often exceeding the linear dynamic range of the GLAS 1064-nm detector assembly. The resulting saturation of the receiver distorted the recorded signal and resulted in range biases as large as 50 cm for ice and snow-covered surfaces. We developed a correction for this saturation range bias based on laboratory tests using a spare flight detector, and refined the correction by comparing GLAS elevation estimates to those derived from Global Positioning System (GPS) surveys over the calibration site at the salar de Uyuni, Bolivia. Applying the saturation correction largely eliminated the range bias due to receiver saturation for affected ICESat measurements over Uyuni and significantly reduced the discrepancies at orbit crossovers located on flat regions of the Antarctic ice sheet

U.S. Inhibitor Pilot Project: Study Design And Methods Validation

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106090/1/jth01876.pd

Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings

BACKGROUND: Randomized controlled trials (RCTs) on pediatric venous thromboembolism (VTE) treatment have been challenged by unsubstantiated design assumptions and/or poor accrual. Pilot/feasibility (P/F) studies are critical to future RCT success. METHODS: The Kids-DOTT trial is a multicenter RCT investigating non-inferiority of a 6-week (shortened) versus 3-month (conventional) duration of anticoagulation in patients aged \u3c 21 years with provoked venous thrombosis. Primary efficacy and safety endpoints are symptomatic recurrent VTE at 1 year and anticoagulant-related, clinically relevant bleeding. In the P/F phase, 100 participants were enrolled in an open, blinded-endpoint, parallel-cohort RCT design. RESULTS: No eligibility violations or randomization errors occurred. Of the enrolled patients, 69% were randomized, 3% missed the randomization window, and 28% were followed in prespecified observational cohorts for completely occlusive thrombosis or persistent antiphospholipid antibodies. Retention at 1 year was 82%. Interobserver agreement between local and blinded central determination of venous occlusion by imaging at 6 weeks after diagnosis was strong (k-statistic = 0.75; 95% confidence interval [CI] 0.48-1.0). The primary efficacy and safety event rates were 3.3% (95% CI 0.3-11.5%) and 1.4% (95% CI 0.03-7.4%). CONCLUSIONS: The P/F phase of the Kids-DOTT trial has demonstrated the validity of vascular imaging findings of occlusion as a randomization criterion, and defined randomization, retention and endpoint rates to inform the fully powered RCT

Confession Session: Learning from Others Mistakes

Accepted versio

Nucleon-nucleon elastic scattering analysis to 2.5 GeV

A partial-wave analysis of NN elastic scattering data has been completed. This analysis covers an expanded energy range, from threshold to a laboratory kinetic energy of 2.5 GeV, in order to include recent elastic pp scattering data from the EDDA collaboration. The results of both single-energy and energy-dependent analyses are described.Comment: 23 pages of text. Postscript files for the figures are available from ftp://clsaid.phys.vt.edu/pub/said/n

Towards Constraining Glacial Isostatic Adjustment in Greenland Using ICESat and GPS Observations

Constraining glacial isostatic adjustment (GIA) i.e. the Earth’s viscoelastic response to past ice changes, is an important task, because GIA is a significant correction in gravity-based ice sheet mass balance estimates. Here, we investigate how temporal variations in the observed and modeled crustal displacements due to the Earth’s response to ongoing ice mass changes can contribute to the process of constraining GIA. We use mass change grids of the Greenland ice sheet (GrIS) derived from NASA’s high resolution Ice, Cloud and land Elevation Satellite (ICESat) data in three overlapping time spans covering the period 2004–2009 to estimate temporal variations in the elastic response due to present day ice mass loss. The modeled crustal displacements (elastic + GIA) are compared with GPS time series from five permanent sites (KELY, KULU, QAQ1, THU2, and SCOR). We find, that the modeled pattern of elastic crustal displacements shows pronounced variation during the observation period, where an increase in elastic displacement is found at the northwest coast of Greenland, while a decrease is found at the southeast coast. This pattern of temporal changes is supported by the GPS observations. We find, that the temporal behavior of the ICESat-based modeled elastic response agrees well with the GPS observations at the sites KELY, QAQ1, and SCOR. This suggests, that our elastic models are able to resolve the temporal changes in the observed uplift, which indicates that the elastic uplift models are reliable at these sites. Therefore, we conclude that these sites are useful for constraining GIA

Prophylaxis escalation in severe von Willebrand disease: A prospective study from the von Willebrand Disease Prophylaxis Network

Background: Treatment of mucosal bleeding (epistaxis, gastrointestinal bleeding, and menorrhagia) and joint bleeding remains problematic in clinically severe von Willebrand disease (VWD). Patients are often unresponsive to treatment (e.g. desmopressin or antifibrinolytic therapy) and may require von Willebrand factor (VWF) replacement therapy. There are little data on the use of prophylaxis in VWD, and none have been applied in a prospective, treatment escalation design. Objective: Evaluate the effect of escalating dose prophylaxis in severe VWD. Methods: Patients eligible for enrollment in this prospective study included those with type 1 VWD with VW factor activity-ristocetin cofactor ratio ≤ 20% and unresponsive to desmopressin, patients with type 2 VWD not responsive to desmopressin and all subjects with type 2B and type 3 VWD. Entry criteria were strictly defined, as were therapy escalation parameters and clinical data collection. Results: Eleven subjects completed the study. Six had type 2A, and five had type 3 VWD. Six patients presented with epistaxis, three with GI bleeding, and two with joint bleeding. Seven had dose escalation above the first level. Among the 10 subjects with evaluable bleeding log data, use of prophylaxis decreased the median annualized bleeding rate from 25 to 6.1 (95% confidence interval of the rate difference: -51.6 to -1.7), and the median annualized bleeding rate was even lower (4.0; 95% confidence interval: -57.5 to -5.3) when the subjects reached their final dosing level. Conclusion: This is the first prospective study to demonstrate that prophylaxis with VW factor concentrates is highly effective in reducing mucosal and joint bleeding rates in clinically severe VWD